Direct observation (DO) for drug-resistant tuberculosis: Do we really do?

PLoS ONE

Volumn 10, Issue 12, 2015, Pages

  Benbaba, Stella ^a   Isaakidis, Petros ^a   Das, Mrinalini ^a   Jadhav, Sonakshi ^a   Reid, Tony ^a   Furin, Jennifer ^b  

^a MÉDECINS SANS FRONTIÈRES   (Switzerland)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION; ARTICLE; CHILD; CROSS-SECTIONAL STUDY; DIRECTLY OBSERVED THERAPY; DIZZINESS; FAMILY; FEMALE; FOLLOW UP; HEALTH CARE PERSONNEL; HEALTH CARE PLANNING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; INFANT; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MULTIDRUG RESISTANT TUBERCULOSIS; NAUSEA; PATIENT; PATIENT COMPLIANCE; PRESCHOOL CHILD; PROTOCOL COMPLIANCE; QUESTIONNAIRE; SCHOOL CHILD; SELF REPORT; SIDE EFFECT; SOCIAL STIGMA; VOMITING; WORKLOAD; AGED; MEDICATION COMPLIANCE; MIDDLE AGED; TUBERCULOSIS, MULTIDRUG-RESISTANT; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTITUBERCULAR AGENTS; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; TUBERCULOSIS, MULTIDRUG-RESISTANT; YOUNG ADULT;

EID: 84957991478     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0144936     Document Type: Article

References (13)

1. World Health Organization (WHO) (2014), Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis. WHO Press, Geneva. WHO/HTM/TB/2014.11.
2. Curry International Tuberculosis Center and California Department of Public Health (2011). Drug- Resistant Tuberculosis: A Survival Guide for Clinicians, Second Edition. Available: Www.currytbcenter. ucsf.edu/drtb. Accessed 07 May 2015.
3. Isaakidis P, Rangan S, Pradhan A, Ladomirska J, Reid T, Kielmann K (2013) "I cry everyday": Experiences of patients co-infected with HIV and multidrug-resistant tuberculosis. Trop Med Int Health 18 (9): 1128-1133. doi: 10.1111/tmi.12146 PMID: 23837468
4. Furin J, Isaakidis P, Reid AJ, Kielmann K (2014) 'I'm fed up': Experiences of prior anti-tuberculosis treatment in patients with drug-resistant tuberculosis and HIV. Int J Tuberc Lung Dis 18(12): 1479-1484. PMID: 25517815
5. World Health Organization (WHO) (2014), Tuberculosis country profiles. Available: Http://www.who.int/tb/country/data/profiles/en/. Accessed 07 May 2015.
6. Okanurak K, Kitayaporn D, Waranagisikul W, Koompnag C (2007) Effectiveness of DOT for tuberculosis treatment outcomes: A prospective cohort study from Bangkok, Thailand. Int J Tuberc Lung Dis. 11(7): 762-768 PMID: 17609051
7. O'Donnell MR, Wolf A, Werner L, Horsburgh CR, Padayatchi N (2014). Adherence in the treatment of patients with extensively drug-resistant tuberculosis and HIV in South Africa: A prospective cohort study. J Acquir Immune Defic Syndr 67(1): 22-29. doi: 10.1097/QAI.0000000000000221 PMID: 24872138
8. World Health Organization (WHO) (2013), Global strategy and targets for tuberculosis prevention, care and control after 2015. Draft Post-2015 Global Tuberculosis Strategy Framework. EB 134/12. Available: Http://www.paho.org/bireme/images/2who-strategy.pdf. Accessed 07 May 2015.
9. Daftary A, Padayatchi N, O'Donnell M (2014) Preferential adherence to antiretroviral therapy over tuberculosis treatment: A qualitative study of drug-resistant TB/HIV co-infected patients in South Africa. Glob Public Health 9(9): 1107-1116. doi: 10.1080/17441692.2014.934266 PMID: 25035943
10. Toczek A, Cox H, du Cros P, Cooke G, Ford N (2013) Strategies for reducing treatment default in drugresistant tuberculosis: Systematic review and meta-analysis. Int J Tuberc Lung Dis 17(3): 299-307. doi: 10.5588/ijtld.12.0537 PMID: 23211716
11. Volmink J, Garner P (2007) Directly observed therapy for treating tuberculosis. Cochrane Database Syst Rev 17; (4): CD003343.
12. Pasipanodya JG, Gumbo T (2013) A meta-analysis of self-administered vs directly observed therapy effect on microbiologic failure, relapse, and acquired drug resistance in tuberculosis patients. Clin Infect Dis 57(1): 21-31 doi: 10.1093/cid/cit167 PMID: 23487389
13. Wright CM, Westerkamp L, Korver S, Dobler CC. (2015) Community-based directly observed therapy (DOT) versus clinic DOT for tuberculosis: A systematic review and meta-analysis of comparative effectiveness. BMC Infect Dis; 15: 210 doi: 10.1186/s12879-015-0945-5 PMID: 25948059